Literature DB >> 23307808

NTP-mediated nucleotide excision activity of hepatitis C virus RNA-dependent RNA polymerase.

Zhinan Jin1, Vincent Leveque, Han Ma, Kenneth A Johnson, Klaus Klumpp.   

Abstract

Hepatitis C virus (HCV) RNA-dependent RNA polymerase replicates the viral genomic RNA and is a primary drug target for antiviral therapy. Previously, we described the purification of an active and stable polymerase-primer-template elongation complex. Here, we show that, unexpectedly, the polymerase elongation complex can use NTPs to excise the terminal nucleotide in nascent RNA. Mismatched ATP, UTP, or CTP could mediate excision of 3'-terminal CMP to generate the dinucleoside tetraphosphate products Ap(4)C, Up(4)C, and Cp(4)C, respectively. Pre-steady-state kinetic studies showed that the efficiency of NTP-mediated excision was highest with ATP. A chain-terminating inhibitor, 3'deoxy-CMP, could also be excised through this mechanism, suggesting important implications for nucleoside drug potency and resistance. The nucleotide excision reaction catalyzed by recombinant hepatitis C virus polymerase was 100-fold more efficient than the corresponding reaction observed with HIV reverse transcriptase.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23307808      PMCID: PMC3562815          DOI: 10.1073/pnas.1214924110

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  47 in total

1.  Only a small fraction of purified hepatitis C RNA-dependent RNA polymerase is catalytically competent: implications for viral replication and in vitro assays.

Authors:  S S Carroll; V Sardana; Z Yang; A R Jacobs; C Mizenko; D Hall; L Hill; J Zugay-Murphy; L C Kuo
Journal:  Biochemistry       Date:  2000-07-18       Impact factor: 3.162

2.  Exonuclease proofreading by human mitochondrial DNA polymerase.

Authors:  A A Johnson; K A Johnson
Journal:  J Biol Chem       Date:  2001-07-26       Impact factor: 5.157

3.  3'-Azido-3'-deoxythymidine-(5')-tetraphospho-(5')-adenosine, the product of ATP-mediated excision of chain-terminating AZTMP, is a potent chain-terminating substrate for HIV-1 reverse transcriptase.

Authors:  Sanjeewa Dharmasena; Zita Pongracz; Eddy Arnold; Stefan G Sarafianos; Michael A Parniak
Journal:  Biochemistry       Date:  2007-01-23       Impact factor: 3.162

4.  Global kinetic explorer: a new computer program for dynamic simulation and fitting of kinetic data.

Authors:  Kenneth A Johnson; Zachary B Simpson; Thomas Blom
Journal:  Anal Biochem       Date:  2008-12-25       Impact factor: 3.365

5.  Intracellular substrates for the primer-unblocking reaction by human immunodeficiency virus type 1 reverse transcriptase: detection and quantitation in extracts from quiescent- and activated-lymphocyte subpopulations.

Authors:  Anthony J Smith; Peter R Meyer; Deshratn Asthana; Margarita R Ashman; Walter A Scott
Journal:  Antimicrob Agents Chemother       Date:  2005-05       Impact factor: 5.191

6.  Evolution of AZT resistance in HIV-1: the 41-70 intermediate that is not observed in vivo has a replication defect.

Authors:  R E Jeeninga; W Keulen; C Boucher; R W Sanders; B Berkhout
Journal:  Virology       Date:  2001-05-10       Impact factor: 3.616

7.  2'-deoxy-4'-azido nucleoside analogs are highly potent inhibitors of hepatitis C virus replication despite the lack of 2'-alpha-hydroxyl groups.

Authors:  Klaus Klumpp; Genadiy Kalayanov; Han Ma; Sophie Le Pogam; Vincent Leveque; Wen-Rong Jiang; Nicole Inocencio; Anniek De Witte; Sonal Rajyaguru; Ezra Tai; Sushmita Chanda; Michael R Irwin; Christian Sund; Anna Winqist; Tatiana Maltseva; Staffan Eriksson; Elena Usova; Mark Smith; Andre Alker; Isabel Najera; Nick Cammack; Joseph A Martin; Nils Gunnar Johansson; David B Smith
Journal:  J Biol Chem       Date:  2007-11-14       Impact factor: 5.157

8.  Effects of primer-template sequence on ATP-dependent removal of chain-terminating nucleotide analogues by HIV-1 reverse transcriptase.

Authors:  Peter R Meyer; Anthony J Smith; Suzanne E Matsuura; Walter A Scott
Journal:  J Biol Chem       Date:  2004-08-11       Impact factor: 5.157

9.  Assembly, purification, and pre-steady-state kinetic analysis of active RNA-dependent RNA polymerase elongation complex.

Authors:  Zhinan Jin; Vincent Leveque; Han Ma; Kenneth A Johnson; Klaus Klumpp
Journal:  J Biol Chem       Date:  2012-02-02       Impact factor: 5.157

10.  Selected replicon variants with low-level in vitro resistance to the hepatitis C virus NS5B polymerase inhibitor PSI-6130 lack cross-resistance with R1479.

Authors:  Samir Ali; Vincent Leveque; Sophie Le Pogam; Han Ma; Friederike Philipp; Nicole Inocencio; Mark Smith; Andre Alker; Hyunsoon Kang; Isabel Najera; Klaus Klumpp; Julian Symons; Nick Cammack; Wen-Rong Jiang
Journal:  Antimicrob Agents Chemother       Date:  2008-10-06       Impact factor: 5.191

View more
  20 in total

Review 1.  The uncoupling of catalysis and translocation in the viral RNA-dependent RNA polymerase.

Authors:  Bo Shu; Peng Gong
Journal:  RNA Biol       Date:  2017-03-01       Impact factor: 4.652

2.  Induced intra- and intermolecular template switching as a therapeutic mechanism against RNA viruses.

Authors:  Richard Janissen; Andrew Woodman; Djoshkun Shengjuler; Thomas Vallet; Kuo-Ming Lee; Louis Kuijpers; Ibrahim M Moustafa; Fiona Fitzgerald; Peng-Nien Huang; Angela L Perkins; Daniel A Harki; Jamie J Arnold; Belén Solano; Shin-Ru Shih; Marco Vignuzzi; Craig E Cameron; Nynke H Dekker
Journal:  Mol Cell       Date:  2021-10-22       Impact factor: 17.970

Review 3.  HIV-1 reverse transcriptase and antiviral drug resistance. Part 2.

Authors:  Kalyan Das; Eddy Arnold
Journal:  Curr Opin Virol       Date:  2013-04-19       Impact factor: 7.090

4.  Efficiency of incorporation and chain termination determines the inhibition potency of 2'-modified nucleotide analogs against hepatitis C virus polymerase.

Authors:  Amy Fung; Zhinan Jin; Natalia Dyatkina; Guangyi Wang; Leo Beigelman; Jerome Deval
Journal:  Antimicrob Agents Chemother       Date:  2014-04-14       Impact factor: 5.191

5.  Backtracking behavior in viral RNA-dependent RNA polymerase provides the basis for a second initiation site.

Authors:  David Dulin; Igor D Vilfan; Bojk A Berghuis; Minna M Poranen; Martin Depken; Nynke H Dekker
Journal:  Nucleic Acids Res       Date:  2015-10-22       Impact factor: 16.971

6.  Thumb Site 2 Inhibitors of Hepatitis C Viral RNA-dependent RNA Polymerase Allosterically Block the Transition from Initiation to Elongation.

Authors:  Jiawen Li; Kenneth A Johnson
Journal:  J Biol Chem       Date:  2016-02-05       Impact factor: 5.157

Review 7.  Dissecting nucleotide selectivity in viral RNA polymerases.

Authors:  Chunhong Long; Moises Ernesto Romero; Daniel La Rocco; Jin Yu
Journal:  Comput Struct Biotechnol J       Date:  2021-06-04       Impact factor: 7.271

8.  Resistance to excision determines efficiency of hepatitis C virus RNA-dependent RNA polymerase inhibition by nucleotide analogs.

Authors:  Brian Villalba; Jiawen Li; Kenneth A Johnson
Journal:  J Biol Chem       Date:  2020-05-26       Impact factor: 5.157

9.  Biochemical Effect of Resistance Mutations against Synergistic Inhibitors of RSV RNA Polymerase.

Authors:  Jerome Deval; Amy Fung; Sarah K Stevens; Paul C Jordan; Tatiana Gromova; Joshua S Taylor; Jin Hong; Jia Meng; Guangyi Wang; Natalia Dyatkina; Marija Prhavc; Julian A Symons; Leo Beigelman
Journal:  PLoS One       Date:  2016-05-10       Impact factor: 3.240

10.  Rate-limiting pyrophosphate release by hepatitis C virus polymerase NS5B improves fidelity.

Authors:  Brian Villalba; Kenneth A Johnson
Journal:  J Biol Chem       Date:  2020-09-16       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.